Aminoglykosid-induced nephrotoxity;Aminoglykosid-induzierte Nephrotoxizitat

Wiener Klinische Wochenschrift

Volumn 109, Issue 21, 1997, Pages 830-835

  Fabrizii, Veronika ^a   Thalhammer, Florian ^a   Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aminoglycosides; Efficacy; Nephrotoxicity; Once daily therapy; Prevention; Risk factors for toxicity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ANTIBACTERIAL ACTIVITY; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; BLOOD; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; METABOLIC CLEARANCE RATE; PHYSIOLOGY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; METABOLIC CLEARANCE RATE; RISK FACTORS;

EID: 0031567696     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Siegenthaler WE, Bonctti A, Lughy R (1986) Aminoglycoside antibiotics in infectious disease: an overview. Am J Med 80 [Suppl] 6B: 2-14
2. Moellering RC (1986) Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections? Am J Med 80 [Suppl] 6B: 44-47
3. Appel GB, Neu HC (1977) The nephrotoxicity of antimicrobial agents. N Engl J Med 296: 663-670
4. Bennett WM, Luft F, Porter GA (1980) Pathogenesis of renal failure due to aminoglycosides and contrast media used in roentgenography. Am J Med 69: 767-774
5. Barclay ML, Begg EJ, Hickling KG (1994) What is the evidence for once-daily aminoglycoside therapy. Clin Pharmacokinet 27: 32-48
6. Barza M, Brown RB, Shen D, Gibaldi M, Weinstein L (1975) Predictability of blood levels of gentamicin in man. J Infect Dis 132: 165-174
7. Davies RR, Brummett RE, Bendrick TW, Himes DL (1984) Dissociation of maximum concentration of kanamycin in plasma and perilymph from ototoxic effect. J Antimicrob Chemother 14: 291-302
8. Levy J (1986) Antibiotic activity in sputum. J Pediatr 108: 841-846
9. Strausbaugh LJ, Mandaleris CD, Sande MA (1977) Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meninigitis. J Lab Clin Med 89: 692-701
10. Noone P, Parsons TMC, Pattison JR, Slack RC, Garfield-Davies D, Hughes K (1974) Experience in monitoring gentamicin therapy during treatment of serious gram negative sepsis. BMJ 1: 477-481
11. Moore RD, Smith CR, Lietman PS (1984) The association of aminoglycoside plasma levels with mortality in patients with gram negative bacteremia. J Infect Dis 149: 443-448
12. Moore RD, Smith CR, Lietman PS (1984) Association of plasma levels with therapeutic outcome in gram negative pneumonia. Am J Med 77: 657-662
13. Fantin B, Ebert S, Leggett J, Vogelman B, Craig WA (1991) Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. J Antimicrob Chemother 27 :829-836
14. Kaloyanides GJ (1994) Antibiotic-related nephrotoxicity. Nephrol Dial Transplant 9 [Suppl] 4: 130-134
15. Kaloyanides GJ (1991) Metabolic interactions between drugs and renal tubulo-interstitial cells: role in nephrotoxicity. Kidney Int 39: 531-540
16. Kahlmeter G, Dahlager J (1984) Aminoglycoside toxicity-A review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 13 [Suppl A]: 9-22
17. Kaloyanides GJ (1993) Aminoglycoside nephrotoxicity. In: Schrier RW, Gottschalk CW (eds) Diseases of the kidney, 5th edn. Little Brown & Co, Boston, pp 1131-1164
18. Giurgea-Marion L, Toubeau G, Laurent G, Heuson-Stiennon JA, Tulkens PM (1986) Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol Appl Pharmacol 86: 271-285
19. Appel GB (1990) Aminoglycoside nephrotoxicity. Am J Med 88 [Suppl 3C]: 3C: 16S-3C 20S
20. Neugarten J, Aynedjian HS, Bank N (1983) The role of tubular obstruction in acute renal failure due to gentamicin. Kidney Int 24: 330-335
21. Baylis C, Rennke HR, Brenner BM (1977) Mechanisms of the defect in the glomerular ultrafiltration associated with gentamicin administration. Kidney Int 12: 344-353
22. Giuliano RA, Verpooten GA, Verbist L, Wedeen RP, De Broe ME (1986) In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther 236: 470-475
23. Brier ME, Mayer PR, Brier RA Visscher D, Luft FC, Aronoff GR (1985) Relationship between rat renal accumulation of gentamicin, tobramycin and netilmicin and their nephrotoxicities. Antimicrob Agents Chemother 27: 812-816
24. Meyer RD (1986) Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides. Am J Med 80 [Suppl] 6B: 119-125
25. Lam YW, Arana CJ, Shikuma LR, Rotshafer JC (1986) The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicity. JAMA 255: 639-642
26. Zager RA (1992) Endotoxemia, renal hypoperfusion and fever: interactive risk factors for aminoglycoside and sepsis associated acute renal failure. Am J Kidney Dis 20: 223-230
27. Appel GB, Given DB, Levine LR, Cooper GL (1986) Vancomycin and the kidney. Am J Kidney Dis 8: 75-80
28. Wold S, Turnipseed SA (1981) Toxicity of vancomycin in laboratory animals. Rev Infect Dis 3 [Suppl.]: 224-235
29. Hsu CH, Kurtz TW, Easterling RE, Weller JM (1974) Potentiation of gentamicin nephrotoxicity by metabolic acidosis. Proc Soc Exp Biol Med 146: 894-897
30. Peterson LN, (1990) Inhibition of tobramycin reabsorption in nephron segments by metabolic alkalosis. Kidney Int 37: 1492-1499
31. Elliott WC, Parker RA, Houghton DC, Gilbert DN, Porter GA, DeFehr J, Bennett WM (1980) Effect of sodium bicarbonate and ammonium chloride ingestion in experimental gentamicin nephrotoxicity. Res Commun Chem Pathol Pharmacol 28: 483-495
32. Aynedjian HS, Nguyen D, Lee HY, Sablay LB, Bank N (1988) Effects of dietary electrolyte supplementation on gentamicin nephrotoxicity Am J Med Sci 295: 444-452
33. Smith CR, Lietman PS (1982) Comparative trials of aminoglycosides. In: Whelton A. Neu HC (eds) The aminoglycosides. Marc Dekker, New York Basel, pp 497-509
34. Cone LA (1982) A survey of prospective controlled randomized trials of gentamicin, tobramycin, amikacin and netilmicin. Clin Ther 5: 155-162
35. McCormack JP, Jewesson PJ (1992) A critical review of the "therapeutic range" of aminoalycosides. Clin Infect Dis 14: 320-329
36. 35a. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH (1997) Once-daily closing of aminoglucosides: review and recommendation for clinical practice. J Antimicrob Chemother 39: 672-686
37. Barza M, Ioannidis JP, Cappelleri JC, Lau J (1996) Single or multiple daily doses of aminoglycosides: a meta analysis. BMJ 312: 338-345
38. Frass M, Traindl O, Podolsky A, Leithner C, Graninger W (1991). Comparison of once-daily versus thrice daily dosage of netilmycin in critically ill patients. Wien Klin Wochenschr 103: 101-104
39. Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P (1993) Once versus thrice daily gentamicin in patients with serious infections. Lancet 341: 335-339
40. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a oncedaily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39: 650-655
41. Hatala R, Dinh T, Cook DJ (1996) Once-daily aminoglycoside dosing in immunocompetent adulats: a meta-analysis. Ann Intern Med 124: 717-725
42. Raz R, Adawi M, Romano S (1995) Intravenous administration of gentamicin once daily versus thrice daily in adults. Eur J Clin Microbiol Infect Dis 14: 88-91
43. Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or in divided dosis. J Antimicrob Chemother 37: 645-663
44. Leehey DJ, Braun BI, Tholl DA, Chung LS, Gross CA, Roback JA, Lentino JR (1993) Can pharmacokinetic dosing decrease the nephrotoxicity associated with aminoglycoside therapy? J Am Soc Nephrol 4: 81-90
45. Laczika K, Staudinger T, Hollenstein U, Presterl E, Locker GJ, Knapp S, et al (1997) Renal tolerability of four different once daily dose regimen of netilmicin in the in critical care patients. Wien Klin Wochenschr 109: 840-844
46. Horstkotte D, Piper C, Schultheiss HP (1997) Die akute infektiöse Endokarditis. Wien Klin Wochenschr 109: 105-115
47. Welage LS, Walawander CA, Timm EG, Grasela TH (1994) Risk factors for acute renal insufficiency in patients with suspected or documented bacterial pneumonia. Ann Pharmacother 28: 515-522